Lifecore Biomedical, Inc. (LFCR) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and thank you for joining LifeCorps' earnings call for the first quarter ended March 31st, 2026. During the call, all participants will be in a listen-only mode. Now I would like to turn the call over to Stephanie Diaz, Manager of Investor Relations for LifeCorps. Good morning and thank you for joining us. Today, LifeCorps Biomedical will provide its earnings for the first quarter ended March 31st, 2026 and corporate updates. As the company has recently changed its fiscal year end to align with the calendar year, we will be comparing our results for the first quarter ended March 31st, 2026 with a comparable prior year quarter ended February 23rd, 2025. Hosting the call today from LifeCorps are Paul Josephs, President and Chief Executive Officer, and Ryan Lake, Chief Financial Officer. Before we begin, I'd like to remind everyone that today's conference call will contain forward-looking statements. It is important to note that the forward-looking statements made during this call reflect management's judgment and analysis only as of today, May 6, 2026, and the company's actual results could differ materially from those projected in such forward-looking statements. For a more thorough discussion of the risks and uncertainties associated with any forward-looking statements, please see the disclaimer regarding forward-looking statements that is included in our earnings press release. which was furnished to the Securities and Exchange Commission this morning on form 8K and is available on our corporate website at livecore.com, as well as our other filings with the Securities and Exchange Commission, including but not limited to the company's form 10Q for Q1 2026, which was filed at the SEC this morning and is also available on our website. In addition, our ear...